Julie E. Bolding

767 total citations · 1 hit paper
6 papers, 501 citations indexed

About

Julie E. Bolding is a scholar working on Geriatrics and Gerontology, Epidemiology and Physiology. According to data from OpenAlex, Julie E. Bolding has authored 6 papers receiving a total of 501 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Geriatrics and Gerontology, 4 papers in Epidemiology and 3 papers in Physiology. Recurrent topics in Julie E. Bolding's work include Sirtuins and Resveratrol in Medicine (6 papers), Autophagy in Disease and Therapy (4 papers) and Adenosine and Purinergic Signaling (2 papers). Julie E. Bolding is often cited by papers focused on Sirtuins and Resveratrol in Medicine (6 papers), Autophagy in Disease and Therapy (4 papers) and Adenosine and Purinergic Signaling (2 papers). Julie E. Bolding collaborates with scholars based in Denmark, Switzerland and Australia. Julie E. Bolding's co-authors include Christian A. Olsen, Alexander L. Nielsen, Michael Bæk, Jiemin Wong, Wenchao Liu, Lu Yang, Yingming Zhao, Di Zhang, Jinjun Gao and Wei Wei and has published in prestigious journals such as Angewandte Chemie International Edition, Science Advances and Angewandte Chemie.

In The Last Decade

Julie E. Bolding

6 papers receiving 498 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Class I histone deacetylases (HDAC1–3) are histone lysine delactylases

2022 425 citations Carlos Moreno–Yruela, Di Zhang et al. Science Advances profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Julie E. Bolding Denmark	5	360	164	60	57	54	6	501
Michael Bæk Denmark	6	414 1.1×	183 1.1×	73 1.2×	67 1.2×	60 1.1×	8	564
Clint A. Stalnecker United States	7	284 0.8×	202 1.2×	54 0.9×	22 0.4×	51 0.9×	19	404
Daniela Danková Denmark	4	334 0.9×	163 1.0×	49 0.8×	53 0.9×	21 0.4×	6	437
Christian Argueta United States	13	463 1.3×	53 0.3×	160 2.7×	36 0.6×	43 0.8×	27	631
Miao-chong J. Lin United States	8	182 0.5×	105 0.6×	44 0.7×	42 0.7×	51 0.9×	12	294
Fiorella Faienza Italy	8	320 0.9×	137 0.8×	63 1.1×	28 0.5×	21 0.4×	13	469
Marisa Carbonaro United States	6	231 0.6×	83 0.5×	101 1.7×	18 0.3×	121 2.2×	11	387
Margie N. Sutton United States	13	309 0.9×	106 0.6×	84 1.4×	77 1.4×	25 0.5×	24	474
Gaëlle Bridon Canada	10	413 1.1×	214 1.3×	81 1.4×	32 0.6×	19 0.4×	12	555
Meng Wu China	13	374 1.0×	68 0.4×	57 0.9×	45 0.8×	15 0.3×	21	473

Countries citing papers authored by Julie E. Bolding

Since Specialization

Citations

This map shows the geographic impact of Julie E. Bolding's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Julie E. Bolding with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Julie E. Bolding more than expected).

Fields of papers citing papers by Julie E. Bolding

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Julie E. Bolding. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Julie E. Bolding. The network helps show where Julie E. Bolding may publish in the future.

Co-authorship network of co-authors of Julie E. Bolding

This figure shows the co-authorship network connecting the top 25 collaborators of Julie E. Bolding. A scholar is included among the top collaborators of Julie E. Bolding based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Julie E. Bolding. Julie E. Bolding is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

6 of 6 papers shown

1.

Bolding, Julie E., Alexander L. Nielsen, Tobias Hansen, et al.. (2023). Substrates and Cyclic Peptide Inhibitors of the Oligonucleotide‐Activated Sirtuin 7**. Angewandte Chemie International Edition. 62(49). e202314597–e202314597. 10 indexed citations

2.

Hansen, Tobias, Alexander L. Nielsen, Huy The Nguyen, et al.. (2022). Investigation of Carboxylic Acid Isosteres and Prodrugs for Inhibition of the Human SIRT5 Lysine Deacylase Enzyme**. Angewandte Chemie. 134(22). 4 indexed citations

3.

Bolding, Julie E., Pablo Martín‐Gago, Luke F. Gamon, et al.. (2022). Aryl Fluorosulfate Based Inhibitors That Covalently Target the SIRT5 Lysine Deacylase**. Angewandte Chemie. 134(47). 1 indexed citations

4.

Bolding, Julie E., Pablo Martín‐Gago, Luke F. Gamon, et al.. (2022). Aryl Fluorosulfate Based Inhibitors That Covalently Target the SIRT5 Lysine Deacylase**. Angewandte Chemie International Edition. 61(47). e202204565–e202204565. 36 indexed citations

5.

Hansen, Tobias, Alexander L. Nielsen, Huy The Nguyen, et al.. (2022). Investigation of Carboxylic Acid Isosteres and Prodrugs for Inhibition of the Human SIRT5 Lysine Deacylase Enzyme**. Angewandte Chemie International Edition. 61(22). e202115805–e202115805. 25 indexed citations

6.

Moreno–Yruela, Carlos, Di Zhang, Wei Wei, et al.. (2022). Class I histone deacetylases (HDAC1–3) are histone lysine delactylases. Science Advances. 8(3). eabi6696–eabi6696. 425 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact